Europe · Regional markets · Manager Magazin

Fresenius: Geschäft mit Nachahmer-Arzneien sorgt für höhere Jahresziele

Published by Manager Magazin · Germany 16 h ago

Fresenius profitiert stark vom Geschäft mit Nachahmer-Arzneien, auch das Klinikgeschäft legt zu. Nun sieht der Konzern beim Gewinn für 2026 mehr Spielraum.

Read the full article on Manager Magazin Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.manager-magazin.de)

Also worth reading

This is Money

One of Britain's top female executives to scoop millions as new boss of US tech giant

City A.M.

OBR warns Healey: Stealth taxes to blame for living standards slump

Investors Chronicle

US election results send shares higher

Finews

Private bank appoints branch manager, client advisor and South Africa specialist

MoneyWeek

China is a technology powerhouse: how can you gain exposure?

Maddyness